Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
611.00
+10.00 (1.66%)
Dec 2, 2024, 9:00 AM CST
54.10%
Market Cap 143.06B
Revenue (ttm) 44.43M
Net Income (ttm) -588.83M
Shares Out 153.83M
EPS (ttm) -4.12
PE Ratio n/a
Forward PE 91.13
Dividend n/a
Ex-Dividend Date n/a
Volume 622,615
Average Volume 350,070
Open 604.00
Previous Close 601.00
Day's Range 592.00 - 628.00
52-Week Range 240.50 - 800.00
Beta 0.73
RSI 70.37
Earnings Date Feb 7, 2025

About TPE:6919

Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6919
Full Company Profile

Financial Performance

In 2024, TPE:6919's revenue was 44.43 million, an increase of 14.13% compared to the previous year's 38.93 million. Losses were -588.83 million, 20.5% more than in 2023.

Financial Statements

News

There is no news available yet.